Abstract
Purpose To determine the effect of once-daily 0.005% latanoprost on intraocular pressure (IOP) and pulsatile ocular blood flow (POBF) in patients with normal tension glaucoma (NTG).
Methods The diurnal IOP and sitting POBF were determined for 32 eyes of 19 NTG patients after a washout period. The subjects were treated with 0.005% latanoprost for 3-4 weeks and the measurements repeated. Statistical analysis was performed using the Wilcoxon signed rank test.
Results Median IOP before and after treatment were 19 and 15 mmHg respectively (p < 0.001). The IOP reduction correlated with the initial IOP before treatment (p < 0.01) and was accompanied by an increase in median POBF from 656 to 796 µl/min (p < 0.001).
Conclusions Once-daily treatment with 0.005% latanoprost provides a significant and stable IOP reduction in the majority of NTG patients after short-term treatment. This is accompanied by a significant increase in POBF.
Similar content being viewed by others
Article PDF
References
Klein BE, Klein R, Sponsel WE, Franke T, Cantor LB, Martone J, Menage MJ . Prevalence of glaucoma: the Beaver Dam Eye Study. Ophthalmology 1992;99:1499–504.
Butt Z, McKillop G, O'Brien C, Allan P, Aspinall P . Measurement of ocular blood flow velocity using colour Doppler imaging in low tension glaucoma. Eye 1995;9:29–33.
Drance SM, Sweeney VP, Morgan RW . Studies of factors involved in the production of low tension glaucoma. Arch Ophthalmol 1973;89:457–65.
Bhandari A, Crabb DP, Poinoosawmy D, Fizke FW, Hitchings RA, Noureddin BN . Effect of surgery on visual field progression in normal tension glaucoma. Ophthalmology 1997;104:1131–7.
de Jong N, Greve EL, Hoyng PF, Geijssen HC . Results of a filtering procedure in low tension glaucoma. Int Ophthalmol 1989;13:131–8.
Morsman CD, Bosem ME, Lusky M, Weinreb RN . The effect of topical beta-adrenoceptor blocking agents on pulsatile ocular blood flow. Eye 1995;9:344–7.
Gillow JT, Aggarwal R . Reducing bias during intraocular pressure measurement. Br J Ophthalmol 1995;79:1057–8.
Rulo AH, Greeve EL, Geyssen HC, Hoyng PFJ . Reduction of intraocular pressure with treatment of latanoprost once daily in normal pressure glaucoma patients. Ophthalmology 1996;103:1276–82.
Kjellgren D, Douglas G, Mikelberg F, Drance SM, Alm A . The short-time effect of latanoprost in normal pressure glaucoma. Acta Ophthalmol 1995;73:233–6.
Camras CB, Alm A, Watson P, Stjernschantz J . Latanoprost, a prostaglandin analog, for glaucoma therapy. Ophthalmology 1996;103:1916–24.
Schulzer M . Intraocular pressure reduction in normal-tension glaucoma patients. The Normal Tension Glaucoma Study Group. Ophthalmology 1992;99:1468–70.
Hoyng PFJ, Rulo A, Greve E, Watson P, ALm A . The additive intraocular pressure lowering effect in combined therapy with other ocular hypotensive agents. Surv Ophthalmol 1997;41(Suppl 2):93–8.
Kitizawa Y . Unilateral normal tension glaucoma. J Glaucoma 1997;6:50–5.
Meier-Gibbons F, StUrmer J, Gloor B . Normal pressure glaucoma: a diagnostic challenge. Klin Monatsbl Augenheilkd 1995;206:157–60.
Brubaker RF . Flow of aqueous humour in humans. Invest Ophthalmol Vis Sci 1991;32:3145–66.
James CB, Smith SE . Pulsatile ocular blood flow in patients with low tension glaucoma. Br J Ophthalmol 1991;75:466–70.
Fontana L, Poinoosawmy P, Bunce CV, O'Brien C, Hitchings R . Pulsatile ocular blood flow in asymmetric normal tension glaucoma and normal subjects. Br J Ophthalmol 1998;82:731–6.
Nicolela MT, Buckley AR, Walman BE, Drance SM . A comparative study of the effect of timolol and lanatoprost on blood flow velocity of the retrobulbar vessels. Am J Ophthalmol 1996;122:784–9.
Drance SM, Crichton A, Mills RP . Comparison of the effect of latanoprost 0.005% and timolol 0.5% on the calculated ocular perfusion pressure in patients with normal tension glaucoma. Am J Ophthalmol 1998;125:585–92.
Greve EL, Rulo AH, Drance SM, Crichton AC, Mills RP, Hoyng PFJ . Reduced intraocular pressure and increased ocular perfusion pressure in normal tension glaucoma: a review of short term studies with three dose regimens of latanoprost treatment. Surv Ophthalmol 1997;41(Suppl 2):89–92.
Yang YC, Hulbert MF, Batterbury M, Clearkin LG . Pulsatile ocular blood flow measurements in healthy eyes: reproducibility and reference values. J Glaucoma 1997;6:175–9.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McKibbin, M., Menage, M. The effect of once-daily latanoprost on intraocular pressure and pulsatile ocular blood flow in normal tension glaucoma. Eye 13, 31–34 (1999). https://doi.org/10.1038/eye.1999.6
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/eye.1999.6
Keywords
This article is cited by
-
Long-term Safety and Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: The JUPITER Study
Advances in Therapy (2016)
-
Evaluation of the Effect of Latanoprostene Bunod Ophthalmic Solution, 0.024% in Lowering Intraocular Pressure over 24 h in Healthy Japanese Subjects
Advances in Therapy (2015)
-
Effects of antiglaucoma drugs on blood flow of optic nerve heads and related structures
Japanese Journal of Ophthalmology (2013)
-
Latanoprost effectively ameliorates glucose and lipid disorders in db/db and ob/ob mice
Diabetologia (2013)
-
Efficacy and safety of tafluprost in normal-tension glaucoma with intraocular pressure of 16 mmHg or less
Japanese Journal of Ophthalmology (2011)